QUINOLONE COMPOUNDS FOR USE IN TREATING VIRAL INFECTIONS

The present invention relates to quinolone compounds, such as compounds of formula (Ia) wherein: R is hydrogen; R is oxygen or sulfur; R is trifluoromethyl; cyano; C1-8alkyl optionally substituted with C1-8alkyl or trifluoromethyl; or OR , wherein R is C1-8alkyl optionally substituted with C1-8alkyl...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: FREEMAN, GEORGE, ANDREW, HOPKINS, ANDREW, LEE, ANDREWS, CLARENCE, WEBSTER, III
Format: Patent
Sprache:eng ; fre
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator FREEMAN, GEORGE, ANDREW
HOPKINS, ANDREW, LEE
ANDREWS, CLARENCE, WEBSTER, III
description The present invention relates to quinolone compounds, such as compounds of formula (Ia) wherein: R is hydrogen; R is oxygen or sulfur; R is trifluoromethyl; cyano; C1-8alkyl optionally substituted with C1-8alkyl or trifluoromethyl; or OR , wherein R is C1-8alkyl optionally substituted with C1-8alkyl; R is OR , wherein R is C2-8alkenyl optionally substituted with C1-8alkyl; C1-8alkyl optionally substituted with C1-8alkyl; C6-14arylalkyl; C3-6cycloalkyl; C3-6cycloalkylalkyl; heterocyclealkyl; heterocyclealkynyl; C3-6cycloalkylalkenyl; C6-14arylalkynyl; C3-6cycloalkylalkynyl; SR , wherein R is C3-6cycloalkyl; S(O)R , wherein R is C3-6cycloalkyl; or NR R wherein R and R , which may be the same or different, are hydrogen or C1-8alkyl, optionally substituted with C1-8alkyl; R is hydrogen; nitro; halogen; C1-8alkyl, optionally substituted with C1-8alkyl or trifluoromethyl; R is hydrogen; halogen; C1-8alkyl; cyano: trifluoromethyl; or OR wherein R is C1-8alkyl or trifluoromethyl; R is hydrogen; C1-8alkyl; halogen; C6-14aryl; C1-8alkylaryl; C2-8alkynyl; heteroaryl; or OR wherein R is C1-8alkyl; R is hydrogen; halogen; cyano; nitro; or OR , wherein R is hydrogen or C1-8alkyl optionally substituted with C1-8alkyl or trifluoromethyl; and their use in the treatment of viral infections. The present invention relates to quinolone compounds and their use in the treatment of viral infections. La présente invention concerne des composés de quinolone et leur utilisation dans le traitement d'infections virales.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_WO0146150A2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>WO0146150A2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_WO0146150A23</originalsourceid><addsrcrecordid>eNrjZLAIDPX08_fx93NVcPb3DfAP9XMJVnDzD1IIDXZV8PRTCAlydQzx9HNXCPMMcvQBiri5Ood4-vsF8zCwpiXmFKfyQmluBgU31xBnD93Ugvz41OKCxOTUvNSS-HB_A0MTM0NTA0cjYyKUAAAzIyhY</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>QUINOLONE COMPOUNDS FOR USE IN TREATING VIRAL INFECTIONS</title><source>esp@cenet</source><creator>FREEMAN, GEORGE, ANDREW ; HOPKINS, ANDREW, LEE ; ANDREWS, CLARENCE, WEBSTER, III</creator><creatorcontrib>FREEMAN, GEORGE, ANDREW ; HOPKINS, ANDREW, LEE ; ANDREWS, CLARENCE, WEBSTER, III</creatorcontrib><description>The present invention relates to quinolone compounds, such as compounds of formula (Ia) wherein: R is hydrogen; R is oxygen or sulfur; R is trifluoromethyl; cyano; C1-8alkyl optionally substituted with C1-8alkyl or trifluoromethyl; or OR , wherein R is C1-8alkyl optionally substituted with C1-8alkyl; R is OR , wherein R is C2-8alkenyl optionally substituted with C1-8alkyl; C1-8alkyl optionally substituted with C1-8alkyl; C6-14arylalkyl; C3-6cycloalkyl; C3-6cycloalkylalkyl; heterocyclealkyl; heterocyclealkynyl; C3-6cycloalkylalkenyl; C6-14arylalkynyl; C3-6cycloalkylalkynyl; SR , wherein R is C3-6cycloalkyl; S(O)R , wherein R is C3-6cycloalkyl; or NR R wherein R and R , which may be the same or different, are hydrogen or C1-8alkyl, optionally substituted with C1-8alkyl; R is hydrogen; nitro; halogen; C1-8alkyl, optionally substituted with C1-8alkyl or trifluoromethyl; R is hydrogen; halogen; C1-8alkyl; cyano: trifluoromethyl; or OR wherein R is C1-8alkyl or trifluoromethyl; R is hydrogen; C1-8alkyl; halogen; C6-14aryl; C1-8alkylaryl; C2-8alkynyl; heteroaryl; or OR wherein R is C1-8alkyl; R is hydrogen; halogen; cyano; nitro; or OR , wherein R is hydrogen or C1-8alkyl optionally substituted with C1-8alkyl or trifluoromethyl; and their use in the treatment of viral infections. The present invention relates to quinolone compounds and their use in the treatment of viral infections. La présente invention concerne des composés de quinolone et leur utilisation dans le traitement d'infections virales.</description><edition>7</edition><language>eng ; fre</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2001</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20010628&amp;DB=EPODOC&amp;CC=WO&amp;NR=0146150A2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25562,76317</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20010628&amp;DB=EPODOC&amp;CC=WO&amp;NR=0146150A2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>FREEMAN, GEORGE, ANDREW</creatorcontrib><creatorcontrib>HOPKINS, ANDREW, LEE</creatorcontrib><creatorcontrib>ANDREWS, CLARENCE, WEBSTER, III</creatorcontrib><title>QUINOLONE COMPOUNDS FOR USE IN TREATING VIRAL INFECTIONS</title><description>The present invention relates to quinolone compounds, such as compounds of formula (Ia) wherein: R is hydrogen; R is oxygen or sulfur; R is trifluoromethyl; cyano; C1-8alkyl optionally substituted with C1-8alkyl or trifluoromethyl; or OR , wherein R is C1-8alkyl optionally substituted with C1-8alkyl; R is OR , wherein R is C2-8alkenyl optionally substituted with C1-8alkyl; C1-8alkyl optionally substituted with C1-8alkyl; C6-14arylalkyl; C3-6cycloalkyl; C3-6cycloalkylalkyl; heterocyclealkyl; heterocyclealkynyl; C3-6cycloalkylalkenyl; C6-14arylalkynyl; C3-6cycloalkylalkynyl; SR , wherein R is C3-6cycloalkyl; S(O)R , wherein R is C3-6cycloalkyl; or NR R wherein R and R , which may be the same or different, are hydrogen or C1-8alkyl, optionally substituted with C1-8alkyl; R is hydrogen; nitro; halogen; C1-8alkyl, optionally substituted with C1-8alkyl or trifluoromethyl; R is hydrogen; halogen; C1-8alkyl; cyano: trifluoromethyl; or OR wherein R is C1-8alkyl or trifluoromethyl; R is hydrogen; C1-8alkyl; halogen; C6-14aryl; C1-8alkylaryl; C2-8alkynyl; heteroaryl; or OR wherein R is C1-8alkyl; R is hydrogen; halogen; cyano; nitro; or OR , wherein R is hydrogen or C1-8alkyl optionally substituted with C1-8alkyl or trifluoromethyl; and their use in the treatment of viral infections. The present invention relates to quinolone compounds and their use in the treatment of viral infections. La présente invention concerne des composés de quinolone et leur utilisation dans le traitement d'infections virales.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2001</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZLAIDPX08_fx93NVcPb3DfAP9XMJVnDzD1IIDXZV8PRTCAlydQzx9HNXCPMMcvQBiri5Ood4-vsF8zCwpiXmFKfyQmluBgU31xBnD93Ugvz41OKCxOTUvNSS-HB_A0MTM0NTA0cjYyKUAAAzIyhY</recordid><startdate>20010628</startdate><enddate>20010628</enddate><creator>FREEMAN, GEORGE, ANDREW</creator><creator>HOPKINS, ANDREW, LEE</creator><creator>ANDREWS, CLARENCE, WEBSTER, III</creator><scope>EVB</scope></search><sort><creationdate>20010628</creationdate><title>QUINOLONE COMPOUNDS FOR USE IN TREATING VIRAL INFECTIONS</title><author>FREEMAN, GEORGE, ANDREW ; HOPKINS, ANDREW, LEE ; ANDREWS, CLARENCE, WEBSTER, III</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_WO0146150A23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2001</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>FREEMAN, GEORGE, ANDREW</creatorcontrib><creatorcontrib>HOPKINS, ANDREW, LEE</creatorcontrib><creatorcontrib>ANDREWS, CLARENCE, WEBSTER, III</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>FREEMAN, GEORGE, ANDREW</au><au>HOPKINS, ANDREW, LEE</au><au>ANDREWS, CLARENCE, WEBSTER, III</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>QUINOLONE COMPOUNDS FOR USE IN TREATING VIRAL INFECTIONS</title><date>2001-06-28</date><risdate>2001</risdate><abstract>The present invention relates to quinolone compounds, such as compounds of formula (Ia) wherein: R is hydrogen; R is oxygen or sulfur; R is trifluoromethyl; cyano; C1-8alkyl optionally substituted with C1-8alkyl or trifluoromethyl; or OR , wherein R is C1-8alkyl optionally substituted with C1-8alkyl; R is OR , wherein R is C2-8alkenyl optionally substituted with C1-8alkyl; C1-8alkyl optionally substituted with C1-8alkyl; C6-14arylalkyl; C3-6cycloalkyl; C3-6cycloalkylalkyl; heterocyclealkyl; heterocyclealkynyl; C3-6cycloalkylalkenyl; C6-14arylalkynyl; C3-6cycloalkylalkynyl; SR , wherein R is C3-6cycloalkyl; S(O)R , wherein R is C3-6cycloalkyl; or NR R wherein R and R , which may be the same or different, are hydrogen or C1-8alkyl, optionally substituted with C1-8alkyl; R is hydrogen; nitro; halogen; C1-8alkyl, optionally substituted with C1-8alkyl or trifluoromethyl; R is hydrogen; halogen; C1-8alkyl; cyano: trifluoromethyl; or OR wherein R is C1-8alkyl or trifluoromethyl; R is hydrogen; C1-8alkyl; halogen; C6-14aryl; C1-8alkylaryl; C2-8alkynyl; heteroaryl; or OR wherein R is C1-8alkyl; R is hydrogen; halogen; cyano; nitro; or OR , wherein R is hydrogen or C1-8alkyl optionally substituted with C1-8alkyl or trifluoromethyl; and their use in the treatment of viral infections. The present invention relates to quinolone compounds and their use in the treatment of viral infections. La présente invention concerne des composés de quinolone et leur utilisation dans le traitement d'infections virales.</abstract><edition>7</edition><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; fre
recordid cdi_epo_espacenet_WO0146150A2
source esp@cenet
subjects CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title QUINOLONE COMPOUNDS FOR USE IN TREATING VIRAL INFECTIONS
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-09T16%3A35%3A09IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=FREEMAN,%20GEORGE,%20ANDREW&rft.date=2001-06-28&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EWO0146150A2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true